ADRENAL PRECURSOR C-19 STEROIDS ARE POTENT STIMULATORS OF GROWTH OF ANDROGEN-SENSITIVE MOUSE MAMMARY-CARCINOMA SHIONOGI CELLS-INVITRO

被引：13
作者：
BEGIN, D
LUTHY, IA
LABRIE, F
机构：
来源：
MOLECULAR AND CELLULAR ENDOCRINOLOGY | 1988年 / 58卷 / 2-3期
关键词：
D O I：
10.1016/0303-7207(88)90157-8
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：213 / 219
页数：7
相关论文
共 35 条
[21]   LONG-TERM TREATMENT WITH LUTEINIZING-HORMONE RELEASING HORMONE AGONISTS AND MAINTENANCE OF SERUM TESTOSTERONE TO CASTRATION CONCENTRATIONS [J].
LABRIE, F ;
DUPONT, A ;
BELANGER, A ;
LACHANCE, R ;
GIGUERE, M .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 291 (6492) :369-370
[22]   DEVELOPMENT OF ANDROGEN RESISTANCE IN MOUSE MAMMARY-TUMOR CELLS CAN BE PREVENTED BY THE ANTIANDROGEN FLUTAMIDE [J].
LUTHY, I ;
LABRIE, F .
PROSTATE, 1987, 10 (01) :89-94
[23]   CHARACTERISTICS OF FLUTAMIDE ACTION ON PROSTATIC AND TESTICULAR FUNCTIONS IN THE RAT [J].
MARCHETTI, B ;
LABRIE, F .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 29 (06) :691-698
[24]  
MATSUMOTO K, 1982, HORMONAL REGULATION, V1, P216
[25]   AN ANDROGEN-DEPENDENT TUMOR DERIVED FROM A HORMONE-INDEPENDENT SPONTANEOUS TUMOR OF A FEMALE MOUSE [J].
MINESITA, T ;
YAMAGUCHI, K .
STEROIDS, 1964, 4 (06) :815-830
[26]  
MINESITA T, 1965, CANCER RES, V25, P1168
[27]   PHARMACOLOGY OF AN ANTIANDROGEN, ANANDRON, USED AS AN ADJUVANT THERAPY IN THE TREATMENT OF PROSTATE-CANCER [J].
MOGUILEWSKY, M ;
FIET, J ;
TOURNEMINE, C ;
RAYNAUD, JP .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 24 (01) :139-146
[28]  
NOGUCHI S, 1984, CANCER RES, V44, P5644
[29]  
OJASOO T, 1987, Drugs of the Future, V12, P763
[30]   TESTOSTERONE METABOLISM IN-VIVO BY HUMAN PROSTATIC TISSUE [J].
PIKE, A ;
HARPER, ME ;
PIERREPOINT, CG ;
GRIFFITHS, K .
BIOCHEMICAL JOURNAL, 1970, 120 (02) :443-+
1234